To mark World Alzheimer’s Day, the Canadian Consortium on Neurodegeneration in Aging (CCNA) is launching its signature clinical study, the Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND). Over the next two years, the study will enroll 1600 participants, between the ages of 50 and 90 with memory problems from 30 sites across Canada. The goal will be to learn about who is at risk of developing dementia, how early it can be detected and what tests are most effective at detecting it.
Dr. Jacqueline Pettersen with the Northern Medical Program is one of several researchers participating in the study.
“At the end of it, we’ll be able to develop some tools in order to disagnose dementia earlier, improve quality of life for patients and the families affected by dementia and, ultimately to treatments and prevention.”
The $8.4 million study is funded by the $31.5 million grant awarded for the creation of the CCNA in 2014 by the Government of Canada through the Canadian Institutes of Health Research and 14 partner organizations from the public and private sectors.
Another aim of this study is to further understanding of how dementia impacts women and men differently. It has been shown that women are more likely to develop Alzheimer’s disease than men, while men are more likely to develop vascular dementia than women. What accounts for these discrepancies is little understood and will be a focus of the COMPASS-ND.
Locally, the researchers are hoping to get 20, or more, participants.